I-Mab (IMAB) Stock Forecast & Price Target

→ LIVE DEMO: Elon Musk’s AI hits 65 MPH (From Legacy Research) (Ad)

$1.79

-0.21 (-10.50%)

(As of 02/8/2024 ET)

I-Mab Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 4 Analyst Ratings

Analysts' Consensus Price Target

$19.00
961.45% Upside

High Forecast	$25.00
Average Forecast	$19.00
Low Forecast	$8.00

Type	Current Forecast 2/8/23 to 2/8/24	1 Month Ago 1/9/23 to 1/9/24	3 Months Ago 11/10/22 to 11/10/23	1 Year Ago 2/8/22 to 2/8/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$19.00	$22.75	$22.75	$36.00
Predicted Upside	961.45% Upside	906.64% Upside	927.09% Upside	502.68% Upside

Get I-Mab Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IMAB and its competitors with MarketBeat's FREE daily newsletter.

Ad Weiss Ratings

The Next Nvidia?

Almost every investor has heard of Nvidia. The AI chipmaker became the 7th trillion-dollar company in history. Up 233% this year alone... 9,624% over the last decade. The exciting thing about investing in AI: Nvidia was just the beginning. Over the next few months, I expect a new wave of AI stocks to take the lead. Some could soar even higher than Nvidia.

Click here to find out which three AI stocks I think have the most potential.

IMAB Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

IMAB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

I-Mab Stock vs. The Competition

Type	I-Mab	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.67	2.48
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	1,163.89% Upside	938.37% Upside	9.06% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/8/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$23.00 ➝ $8.00	+334.78%
1/12/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight
8/18/2023	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$25.00 ➝ $18.00	+682.61%
4/3/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight	$30.00 ➝ $25.00	+622.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:13 PM ET.

IMAB Price Target - Frequently Asked Questions

What is I-Mab's consensus rating and price target?: According to the issued ratings of 4 analysts in the last year, the consensus rating for I-Mab stock is Buy based on the current 4 buy ratings for IMAB. The average twelve-month price prediction for I-Mab is $19.00 with a high price target of $25.00 and a low price target of $8.00. Learn more on IMAB's analyst rating history.
Do Wall Street analysts like I-Mab more than its competitors?: Analysts like I-Mab more than other Medical companies. The consensus rating for I-Mab is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how IMAB compares to other companies.
Does I-Mab's stock price have much upside?: According to analysts, I-Mab's stock has a predicted upside of 677.78% based on their 12-month stock forecasts.

What analysts cover I-Mab?: I-Mab has been rated by Cantor Fitzgerald, and Needham & Company LLC in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:IMAB) was last updated on 2/8/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

I-Mab (IMAB) Stock Forecast & Price Target

I-Mab Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

IMAB Analyst Ratings By Month

IMAB Price Targets by Month

I-Mab Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

IMAB Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info